Vitamins
Minerals
Fitness Nutrition
Omega & Fish Oil
Nutritional Drinks
Sexual Wellness
Liver Care
Immunity Boosters
Digestive Care
Diabetic Care
Bone & Joints Care
Respiratory Care
Women Care
Skin Care
Ear Nose Throat
Skin Care
Oral Care
Hair Care
Men Grooming
Baby Food
Baby Hair Care
Baby Skin Care
Baby Bath Care
Diapers
Feminine Hygiene
Women Grooming
Women Nutrition
Blood Glucose
Blood Pressure
Support & Braces
Health Vitals
Test Kits
Nebulizers
Oral Contraceptives
Condoms
Pleasure Enhancers
Protective Gear
Personal & Home
Is the active ingredient. it is a form of erythropoietin, a hormone that stimulates red blood cell production.
Treatment of anemia associated with chronic kidney disease (CKD)
Treatment of anemia in patients with nonmyeloid malignancies receiving chemotherapy
Treatment of anemia in patients undergoing surgery and other medical conditions associated with blood loss
Dargen 25mcg Inj (Darbepoetin Alfa) acts by binding to erythropoietin receptors on erythroid progenitor cells in the bone marrow. This binding stimulates the production and maturation of red blood cells, increasing hemoglobin levels and improving oxygen-carrying capacity of the blood.
Store at 2°C to 8°C (36°F to 46°F). Protect from light. Do not freeze. Discard any unused portion after the expiration date.
Dosage is determined by the physician based on individual needs and response. It is typically administered subcutaneously (under the skin).
The initial dose and subsequent dose adjustments are based on hemoglobin levels, hematocrit, and response to therapy.
Do not administer intravenously.
Redness or pain at the injection site
Hypertension (high blood pressure)
Headache
Nausea
Vomiting
Fatigue
Thromboembolic events (blood clots)
The effect of alcohol consumption on darbepoetin alfa is not well established. Patients should consult their physician.
Patients experiencing side effects such as dizziness or fatigue should avoid driving or operating machinery.
Use during pregnancy and breastfeeding should only be considered if the potential benefits outweigh the potential risks. Consult your physician.
Safety and efficacy in children have not been fully established. Use should be based on individual physician assessment.
Darbepoetin alfa is used to treat anemia related to kidney disease, but careful monitoring is crucial. Dose adjustments may be necessary.
Patients with severe liver impairment require careful monitoring. Dose adjustments may be necessary.
Please consult your physician or refer to the official drug prescribing information for the most accurate and up-to-date details.
